Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behzad Baradaran

Showing results (501-510 of 725) with videos related to

Pageof 73
Sort By:
Immunogenetics|February 15, 2024
Concise review: The heterogenous roles of BATF3 in cancer oncogenesis and dendritic cells and T cells differentiation and function considering the importance of BATF3-dependent dendritic cellsReza Dabbaghipour, Elham Ahmadi, Mona Entezam, et al.
Cytotherapy|March 14, 2024
Dendritic cell vaccination strategy for the treatment of acute myeloid leukemia: a systematic reviewJamal Motallebzadeh Khanmiri, Mohsen Alizadeh, Sina Esmaeili, et al.
Discover Oncology|August 16, 2024
BRD4 expression and its regulatory interaction with miR-26a-3p, DLG5-AS1, and JMJD1C-AS1 lncRNAs in gastric cancer progressionMahya Ahmadpour Youshanlui, Amirhossein Yari, Seyedeh Zahra Bahojb Mahdavi, et al.
Molecular Biology Reports|January 13, 2024
siRNA-mediated downregulation of BATF3 diminished proliferation and induced apoptosis through downregulating c-Myc expression in chronic myelogenous leukemia cellsReza Dabbaghipour, Vahid Khaze Shahgoli, Sahar Safaei, et al.
Cancers|April 29, 2020
Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell DeathZahra Asadzadeh, Elham Safarzadeh, Sahar Safaei, et al.
International Journal of Radiation Biology|March 15, 2017
MLN4924 and 2DG combined treatment enhances the efficiency of radiotherapy in breast cancer cellsMaryam Oladghaffari, Ali Shabestani Monfared, Alireza Farajollahi, et al.
European Journal of Pharmacology|March 12, 2021
Crosstalk between miRNAs and signaling pathways involved in pancreatic cancer and pancreatic ductal adenocarcinomaZiba Lotfi, Shiva Najjary, Fariba Lotfi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 27, 2018
Scrophularia Atropatana Extract Reverses TP53 Gene Promoter Hypermethylation and Decreases Survivin Antiapoptotic Gene Expression in Breast Cancer CellsMehrdad Ghavifekr Fakhr, Kolsoum Rezaie Kahkhaie, Dariush Shanehbandi, et al.
Journal of Cellular Physiology|April 30, 2019
miRNA-143 replacement therapy harnesses the proliferation and migration of colorectal cancer cells in vitroLeila Karimi, Tahereh Zeinali, Nayer Hosseinahli, et al.
Molecular Biology Reports|June 6, 2022
The combined restoration of miR-424-5p and miR-142-3p effectively inhibits MCF-7 breast cancer cell line via modulating apoptosis, proliferation, colony formation, cell cycle and autophagyNarges Dastmalchi, Reza Safaralizadeh, Seyed Mahdi Banan Khojasteh, et al.
Pageof 73

Showing results (501-510 of 725) with videos related to

Sort By:
Pageof 73
Immunogenetics|February 15, 2024
Concise review: The heterogenous roles of BATF3 in cancer oncogenesis and dendritic cells and T cells differentiation and function considering the importance of BATF3-dependent dendritic cellsReza Dabbaghipour, Elham Ahmadi, Mona Entezam, et al.
Cytotherapy|March 14, 2024
Dendritic cell vaccination strategy for the treatment of acute myeloid leukemia: a systematic reviewJamal Motallebzadeh Khanmiri, Mohsen Alizadeh, Sina Esmaeili, et al.
Discover Oncology|August 16, 2024
BRD4 expression and its regulatory interaction with miR-26a-3p, DLG5-AS1, and JMJD1C-AS1 lncRNAs in gastric cancer progressionMahya Ahmadpour Youshanlui, Amirhossein Yari, Seyedeh Zahra Bahojb Mahdavi, et al.
Molecular Biology Reports|January 13, 2024
siRNA-mediated downregulation of BATF3 diminished proliferation and induced apoptosis through downregulating c-Myc expression in chronic myelogenous leukemia cellsReza Dabbaghipour, Vahid Khaze Shahgoli, Sahar Safaei, et al.
Cancers|April 29, 2020
Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell DeathZahra Asadzadeh, Elham Safarzadeh, Sahar Safaei, et al.
International Journal of Radiation Biology|March 15, 2017
MLN4924 and 2DG combined treatment enhances the efficiency of radiotherapy in breast cancer cellsMaryam Oladghaffari, Ali Shabestani Monfared, Alireza Farajollahi, et al.
European Journal of Pharmacology|March 12, 2021
Crosstalk between miRNAs and signaling pathways involved in pancreatic cancer and pancreatic ductal adenocarcinomaZiba Lotfi, Shiva Najjary, Fariba Lotfi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 27, 2018
Scrophularia Atropatana Extract Reverses TP53 Gene Promoter Hypermethylation and Decreases Survivin Antiapoptotic Gene Expression in Breast Cancer CellsMehrdad Ghavifekr Fakhr, Kolsoum Rezaie Kahkhaie, Dariush Shanehbandi, et al.
Journal of Cellular Physiology|April 30, 2019
miRNA-143 replacement therapy harnesses the proliferation and migration of colorectal cancer cells in vitroLeila Karimi, Tahereh Zeinali, Nayer Hosseinahli, et al.
Molecular Biology Reports|June 6, 2022
The combined restoration of miR-424-5p and miR-142-3p effectively inhibits MCF-7 breast cancer cell line via modulating apoptosis, proliferation, colony formation, cell cycle and autophagyNarges Dastmalchi, Reza Safaralizadeh, Seyed Mahdi Banan Khojasteh, et al.
Pageof 73